Concert Pharmaceuticals (CNCE) Reaches $22.11 52-Week High; Northwest Natural Gas Co Has 1.14 Sentiment

November 21, 2017 - By Marie Mckinney

The stock of Concert Pharmaceuticals Inc (NASDAQ:CNCE) hit a new 52-week high and has $23.66 target or 7.00% above today’s $22.11 share price. The 7 months bullish chart indicates low risk for the $503.50 million company. The 1-year high was reported on Nov, 21 by Barchart.com. If the $23.66 price target is reached, the company will be worth $35.25 million more. About 55,441 shares traded. Concert Pharmaceuticals Inc (NASDAQ:CNCE) has risen 18.70% since November 21, 2016 and is uptrending. It has outperformed by 2.00% the S&P500.

Northwest Natural Gas Company is engaged in the distribution of natural gas. The company has market cap of $1.92 billion. The Company’s divisions include Local Gas Distribution, Gas Storage and other. It has a 30.36 P/E ratio. The Firm maintains activities in Oregon, Washington and California and conducts businesses through NW Natural and its subsidiaries.

Investors sentiment increased to 1.13 in Q2 2017. Its up 0.08, from 1.05 in 2017Q1. It increased, as 11 investors sold Concert Pharmaceuticals Inc shares while 21 reduced holdings. 14 funds opened positions while 22 raised stakes. 13.83 million shares or 0.29% more from 13.79 million shares in 2017Q1 were reported. Lyon Street Cap Lc holds 2.44% or 434,752 shares in its portfolio. Manchester Mgmt Ltd Com has invested 0.04% of its portfolio in Concert Pharmaceuticals Inc (NASDAQ:CNCE). Zurcher Kantonalbank (Zurich Cantonalbank) accumulated 4,728 shares or 0% of the stock. Deutsche Savings Bank Ag has 20,834 shares. Manufacturers Life Insur Co The reported 0% in Concert Pharmaceuticals Inc (NASDAQ:CNCE). Alps Inc owns 20,362 shares for 0% of their portfolio. Ameritas Prtnrs has 1,187 shares. 4,429 were accumulated by Legal General Grp Inc Inc Public Limited Company. Highbridge Capital Management Limited stated it has 0% of its portfolio in Concert Pharmaceuticals Inc (NASDAQ:CNCE). Virginia Retirement Et Al stated it has 0% of its portfolio in Concert Pharmaceuticals Inc (NASDAQ:CNCE). California Employees Retirement Sys holds 85,000 shares. Principal Gp Inc has 0% invested in Concert Pharmaceuticals Inc (NASDAQ:CNCE) for 115,100 shares. Jpmorgan Chase & holds 3,099 shares or 0% of its portfolio. Blackrock stated it has 1.11 million shares or 0% of all its holdings. Goldman Sachs Grp reported 0% in Concert Pharmaceuticals Inc (NASDAQ:CNCE).

Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $503.50 million. The Firm is engaged in the discovery and development of small molecule drugs. It has a 5.9 P/E ratio. The Firm operates through the development of pharmaceutical products on its own behalf or in collaboration with others.

Analysts await Concert Pharmaceuticals Inc (NASDAQ:CNCE) to report earnings on March, 5. They expect $-0.58 earnings per share, down 7.41% or $0.04 from last year’s $-0.54 per share. After $-0.70 actual earnings per share reported by Concert Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts -17.14% EPS growth.

Among 9 analysts covering Concert Pharmaceuticals (NASDAQ:CNCE), 8 have Buy rating, 0 Sell and 1 Hold. Therefore 89% are positive. Concert Pharmaceuticals had 19 analyst reports since August 12, 2015 according to SRatingsIntel. As per Wednesday, August 9, the company rating was maintained by H.C. Wainwright. As per Thursday, June 29, the company rating was maintained by Aegis Capital. The rating was maintained by Mizuho with “Buy” on Monday, November 6. The stock of Concert Pharmaceuticals Inc (NASDAQ:CNCE) earned “Buy” rating by Stifel Nicolaus on Thursday, October 19. The stock of Concert Pharmaceuticals Inc (NASDAQ:CNCE) has “Buy” rating given on Tuesday, September 22 by Roth Capital. The firm has “Market Outperform” rating by JMP Securities given on Wednesday, March 9. UBS downgraded the shares of CNCE in report on Monday, November 9 to “Neutral” rating. The stock of Concert Pharmaceuticals Inc (NASDAQ:CNCE) has “Buy” rating given on Monday, September 18 by H.C. Wainwright. The firm has “Buy” rating by TH Capital given on Tuesday, September 22. The firm has “Buy” rating given on Monday, June 12 by Aegis Capital.

Since January 1, 0001, it had 0 insider buys, and 5 insider sales for $815,623 activity.

Clear Harbor Asset Management Llc holds 1.04% of its portfolio in Northwest Natural Gas Co for 89,593 shares. Piermont Capital Management Inc. owns 41,942 shares or 0.72% of their US portfolio. Moreover, Duff & Phelps Investment Management Co has 0.69% invested in the company for 800,000 shares. The Illinois-based Old Republic International Corp has invested 0.51% in the stock. Lucus Advisors Llc, a New York-based fund reported 5,986 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com